LncRNA CASC15 serves as a diagnostic biomarker for postmenopausal osteoporotic fractures and its knockdown enhances HBMSC osteogenic differentiation via miR-152-3p | Synapse
March 3, 2026Open Access
LncRNA CASC15 serves as a diagnostic biomarker for postmenopausal osteoporotic fractures and its knockdown enhances HBMSC osteogenic differentiation via miR-152-3p
Puntos clave
CASC15 serves as a diagnostic biomarker for osteoporotic fractures, linking it to postmenopausal bone health concerns.
The key evidence highlights that knockdown of CASC15 significantly enhances the osteogenic differentiation of HBMSCs by involving miR-152-3p.
Analysis indicates that using HBMSCs emphasizes the role of LncRNA in bone regeneration, positively affecting fracture healing.
The findings may enable targeted strategies in osteoporotic fracture management, hence improving patient outcomes.